Jan
28
2020
On demand
Collaborative development of a new fill/finish instrument
Sponsor
The lack of a robust, scalable solution for autologous cell therapy fill-finish has ensured that this vital final step in the bioprocess remains fraught with challenges. Typically, industry has been forced to resort to a suboptimal, manual syringe and manifold approach.
This webinar examine the very latest technology and its capability to deliver the commercially ready, small volume fill-finish instrument required by industry. In addition, a diverse panel offering expert drug developer, CMO/CRO and tool provider perspectives explore future partnering models and methods for accelerating the novel product development process and further advancing the cell and gene therapy industry.
- Overview of a typical process for developing a new off-the-shelf instrument, including opportunities for user input
- Examples of key learnings from user feedback that had important implications in the development of a new instrument designed for use in fill/finish and other wash/concentrate/formulate/aliquot applications
- Importance of tool provider and customer early data generation
- Tool provider and contract manufacturer perspectives on the most effective ways to collaborate during instrument development and opportunities for the field to improve
